Management of chronic urticaria and angioedema

Standards of Care Committee, British Society for Allergy and Clinical Immunology

It is estimated that chronic urticaria affects 2–3% of individuals (lifetime prevalence) and significantly reduces quality of life. Diagnosis is based primarily on the clinical history. Optimal management of chronic and acute intermittent urticaria depends on a thorough understanding of clinical presentation, aetiology, triggers, and aggravating factors.

This Guidelines summary covers diagnosis and treatment, and also includes a management algorithm.

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us